Key facts
- Nextvisit AI’s last known valuation is $1.8M (Aug 2025).
- It has raised $130K; the latest was Accelerator/Incubator ($130K) in Aug 2025.
- Notable investors include LAUNCH Fund, I2BF Global Ventures, Philippe Masindet.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Nextvisit AI
- ·The full record, as it builds
Funding rounds
No funding rounds for Nextvisit AI are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Nextvisit AI
Developer of an AI-powered medical scribe platform designed to automate clinical documentation for healthcare providers. The company's platform converts patient-provider conversations into structured clinical notes, integrates with electronic health records and reduces manual documentation time, enabling healthcare professionals to efficiently document visits and focus on patient care.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2021
- Employees
- 3
- Website
- nextvisit.ai/
- Ownership
- Privately Held (backing)
Nextvisit AI doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Nextvisit AI shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Nextvisit AI in its N-PORT filings yet. We sweep new filings monthly.